Related Experiment Video

Updated: May 3, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.1K

TPX2 overexpression in medullary thyroid carcinoma mediates TT cell proliferation

Xiaolin Yang1, Geling Liu, Hongzhen Xiao

  • 1Department of Endocrinology (Section I), Tangshan Workers Hospital, Tangshan, China.

Pathology Oncology Research : POR
|February 4, 2014
PubMed

Insights

Targeting protein for xenopus kinesin-like protein 2 (TPX2) is highly expressed in medullary thyroid cancer (MTC). Reducing TPX2 inhibits MTC cell growth and induces apoptosis, suggesting its therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Targeting protein for xenopus kinesin-like protein 2 (TPX2) is a microtubule-associated protein crucial for mitotic spindle formation.
  • Abnormal TPX2 expression is linked to various cancers, but its role in medullary thyroid cancer (MTC) is underexplored.

Purpose of the Study:

  • To investigate TPX2 expression in MTC tissues.
  • To evaluate TPX2 as a potential therapeutic target for MTC.

Main Methods:

  • Immunohistochemical analysis of TPX2 in 32 MTC and 8 normal thyroid tissues.
  • TPX2 knockdown using small interfering RNA (siRNA) in MTC cells.
  • Assessment of cellular effects including proliferation, apoptosis, cell cycle, and gene expression.

Main Results:

  • TPX2 expression was significantly higher in MTC tissues than in normal thyroid tissues (P < 0.05).
  • Elevated TPX2 expression correlated with larger tumor size, lymph node metastasis, and advanced disease stage.
  • TPX2 knockdown induced G1 and G2 cell cycle arrest, inhibited proliferation, promoted apoptosis, and altered expression of key mitotic and tumor suppressor genes (Aurora-A, cyclinB1, p53).

Conclusions:

  • TPX2 is overexpressed in MTC and associated with adverse clinicopathological features.
  • TPX2 plays a significant role in MTC progression.
  • TPX2 represents a promising prognostic marker and therapeutic target for medullary thyroid cancer.

More Related Videos

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

24.0K
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

2.6K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.1K